US2020031879A1PendingUtilityA1
Composition comprising recombinant fusion protein of pathogenic antigen protein and flagellin of vibrio vulnificus for preventing, alleviating, or treating aging
Assignee: UNIV NAT CHONNAM IND FOUNDPriority: Nov 30, 2012Filed: Jul 29, 2019Published: Jan 30, 2020
Est. expiryNov 30, 2032(~6.4 yrs left)· nominal 20-yr term from priority
A61P 1/00A61P 19/00A61K 39/092A61K 38/164C07K 14/28A61K 39/107C07K 2319/00C07K 14/3156A61K 2039/58A61K 38/16A61K 38/17
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a composition for preventing, improving, or treating aging, wherein the composition comprises a recombinant protein of flagellin, which is the constituent of Vibrio vulnificus flagella, fused with a pathogenic protein antigen, as an active component. According to the present invention, the recombinant protein of the present invention can improve external and internal aging-related malfunctions and enhance immunity. Also, the composition of the present invention can easily perform immunization through mucosal administration.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A method for preventing, improving, or treating metabolic disease, the method comprising administering to a subject the composition comprising a recombinant protein of flagellin, which is the constituent of Vibrio vulnificus flagella, fused with a pathogenic protein antigen, as an active ingredient.
13 . The method according to claim 12 , wherein the flagellin is FlaB, which is flagellin of Vibrio vulnificus.
14 . The method according to claim 12 , wherein the pathogenic protein antigen is surface protein A (PspA) of Streptococcus pneumonia.
15 . The method according to claim 12 , wherein the recombinant protein is FlaB-PspA protein having an amino acid sequence of SEQ ID NO: 1.
16 . The method according to claim 12 , wherein the recombinant protein enhances immunity.
17 . The method according to claim 12 , wherein the metabolic disease is caused by aging.
18 . The method according to claim 12 , wherein the metabolic disease is a syndrome in which risk factors, such as obesity, diabetes, hypertriglyceridemia, hypertension, cardiovascular disease, and blood clotting, are shown together.Join the waitlist — get patent alerts
Track US2020031879A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.